An analysis of mortality and morbidity rates for motor neuron disease (MND) in Scotland has confirmed earlier observations that the disease is more common in men and older age groups. The geographical distribution is non-uniform and related to discharge rates for all neurological diseases. Discharge and mortality rates are increasing but there has been no decline in populations who would have been vaccinated against polio.
The general term motor neuron disease (MND) refers to those conditions characterised by progressive muscle wasting and weakness caused by a variable combination of upper and lower motor neuron degeneration. Five to 10% of cases are familial and in some pedigrees there is evidence of a gene conferring disease susceptibility located on chromosome 21 .l' Most cases are sporadic, however, and the low concordance rate demonstrated in twin studies provides strong evidence for an exogenous aetiology in this group. 2 In most patients there is no identifiable cause, and although toxic, metabolic, traumatic, infectious and immunological mechanisms have come under close scrutiny, the aetiology is unknown. 34 There has been longstanding interest in viral hypotheses and the role of poliovirus has received most attention. Charcot was the first to propose a relationship between poliomyelitis and the later development of progressive muscular atrophy in the discussion of a case reported by Raymond5 and the association has since been described in several case series.6 7 8 Evidence for an association is conflicting, however,89 10 and most patients have no history of this condition. Nevertheless, polio infection is usually asymptomatic" and Martyn12 13 Over the same 20 year period, crude mortality rates for MND also increased significantly from 1 25 to 2-1/105 per year (p < 0 05) and age-specific mortality rates rose significantly (p < 0-05) in the 0-19 and 40+ year age groups (table 2) . Age-sex standardised mortality ratios increased significantly from 78 to 124 (p < 0 05) and, whilst the number of patients dying from all neurological diseases increased, the proportion with MND -still rose significantly from 9 5 to 13% (p < 0 05).
Geographical variations
Mortality from progressive muscular atrophy (1931-49) was significantly higher in rural areas (r = 0-51; 95% confidence interval 0 20 to 0 73) and there were negative associations between mortality rates for polio for this early period and more recent first discharge and mortality rates for MND for the period 1968-74 (r =--0 48; 95% confidence interval -0 71 to -0 16 and r = -0 21; 95% confidence interval -0 52 to 0 15 respectively).
The postcodes of area of residence were available for 2403 (92%) of the MND patients hospitalised for the first time between 1975 and 1987 (table 3, figure 3 ). Significant variations were observed with standard discharge ratios ranging from 34 in the Fife region to 1 19 in the Borders region. Standardised mortality ratios were also non-uniform with values ranging between 77 in the Fife region to 156 in the island areas. Standardised first discharge ratios for MND were inversely related to population density (r = -0 31; 95% confidence interval -0 53 to -0 05) and strongly associated with discharge rates for all neurological conditions (r = 0 78; 95% confidence interval 0 38 to 0 94).
Discussion
Variations in the incidence of MND should provide clues to underlying aetiology, but it is difficult to measure this statistic because the condition is rare and the onset is insidious. In the United Kingdom morbidity and mortality returns are collected routinely by government agencies and these should provide some information about the frequency of this disease. Holloway has observed that first discharge data tend to overestimate incidence by as much as 100% because of false-positive coding and diagnosis,24 and mortality returns tend to under represent incidence because of noncertification in 20-30% of cases.26 29 Despite these problems morbidity and mortality provide upper and lower limits of incidence so it was possible to use these statistics to test the hypothesis that the distribution of poliomyelitis and MND are related.
Age-sex distribution MND morbidity and mortality increased with age and were more common in adult males. The slight decline in the older age groups is probably related to underascertainment. Between 1975 and 1987, 295 (11%) of the first discharge registrations and 88 (7 3%) of mortality returns related to individuals younger These observations would obviously lend support to the hypothesis that MND is caused by an exogenous factor and, if the polio hypothesis is correct, it is possible to predict a rise in disease frequency, reflecting changes in the incidence of poliomyelitis that occurred in the earlier part of the century, followed by a decline after 2010 as the effects of vaccination become apparent.'2 13 Epidemiological studies of serological status indicate, however, that antibodies may be acquired in the second decade of life34 3 and, if such at-risk populations were successfully vaccinated in the 1960s, one would expect to see an effect on morbidity and mortality as these patients enter the third and fourth decades in the 1980s. But, although polio mortality and notification rates have declined to vanishingly low levels, these changes have not been accompanied by any significant reduction in MND mortality or morbidity in populations who would have been vaccinated.
Geographical variations
In this study there was no evidence of a geographical association between past mortality from poliomyelitis and present morbidity or mortality from MND. It was not possible to replicate Martyn's study exactly because polio notification rates were not available on a regional basis. In an earlier study from Scotland, Holloway observed that the disease was more common in rural areas25 but, while this was also true of the present study, standardised first discharge ratios were more strongly correlated with discharge rates for all neurological diseases, indicating that the observed trends might be related to variations in ascertainment.
To conclude, we have found no evidence that MND is caused by early asymptomatic polio infection or that polio vaccination offers protection against this condition. However, these results must be interpreted with caution because the population is small and both geographical and temporal trends can be biased by variations in case ascertainment and data collection. It will therefore be of critical importance to monitor the incidence of MND in vaccinated populations and perform casecontrol studies to examine social conditions and vaccination status in early life.
